Mutations in CUL7, OBSL1 and CCDC8 in 3-M syndrome lead to disordered growth factor signalling
Dan Hanson(Nanostring Technologies (United States)), Peter Clayton(Manchester Academic Health Science Centre)
Cited by 57
Related Papers
Management of the Child Born Small for Gestational Age through to Adulthood: A Consensus Statement of the International Societies of Pediatric Endocrinology and the Growth Hormone Research Society
|The Journal of Clinical Endocrinology & Metabolism|2007|724
Safety of growth hormone replacement in survivors of cancer and intracranial and pituitary tumours: a consensus statement
|European Journal of Endocrinology|2022|111
Safety and Efficacy of Pediatric Growth Hormone Therapy: Results From the Full KIGS Cohort
|The Journal of Clinical Endocrinology & Metabolism|2022|106
60 YEARS OF NEUROENDOCRINOLOGY: The hypothalamo-GH axis: the past 60 years
|Journal of Endocrinology|2015|78
3-M syndrome: a growth disorder associated with IGF2 silencing
|Endocrine Connections|2013|22